Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance.

scientific article

Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/ACSNANO.6B04001
P932PMC publication ID6291352
P698PubMed publication ID27579996

P50authorLisa H TostanoskiQ59427648
P2093author name stringMing Guo
Peipei Zhang
Christopher M Jewell
Walter Royal
James I Andorko
Yu-Chieh Chiu
Xiangbin Zeng
P2860cites workAn Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune SystemsQ44625295
Surface-engineered polyelectrolyte multilayer capsules: synthetic vaccines mimicking microbial structure and functionQ49030612
Nanoporous polyelectrolyte vaccine microcarriers. A formulation platform for enhancing humoral and cellular immune responsesQ49054872
Polyelectrolyte microcapsules as antigen delivery vehicles to dendritic cells: uptake, processing, and cross-presentation of encapsulated antigensQ49123460
Mechanically tunable, self-adjuvanting nanoengineered polypeptide particles.Q51005289
Novel Hollow Polymer Shells by Colloid-Templated Assembly of Polyelectrolytes.Q52803764
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE.Q53015646
A Suppressive Oligodeoxynucleotide Enhances the Efficacy of Myelin Cocktail/IL-4-Tolerizing DNA Vaccination and Treats Autoimmune DiseaseQ61853102
Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell ResponseQ85278186
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsQ27860460
Laminins affect T cell trafficking and allograft fateQ30577194
Matrix polyelectrolyte microcapsules: new system for macromolecule encapsulation.Q31170009
Protein encapsulation via porous CaCO3 microparticles templatingQ33206684
Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-betaQ34117705
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosisQ34312767
Interferon‐β inhibits toll‐like receptor 9 processing in multiple sclerosisQ34680345
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cellsQ34947419
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological toleranceQ34985424
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitisQ36094091
Toll-like receptor 4 signaling in T cells promotes autoimmune inflammationQ36167500
Modular Vaccine Design Using Carrier-Free Capsules Assembled from Polyionic Immune Signals.Q36376261
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancyQ36398777
Engineering antigens for in situ erythrocyte binding induces T-cell deletionQ36512070
Antigen kinetics determines immune reactivityQ36516144
Intrinsic immunogenicity of rapidly-degradable polymers evolves during degradationQ36581724
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitisQ36661068
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasomeQ37070610
Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosisQ37679881
Spray-assisted polyelectrolyte multilayer buildup: from step-by-step to single-step polyelectrolyte film constructions.Q37978827
Polymeric multilayer capsules for drug deliveryQ37979152
TLR7 and TLR9 in SLE: when sensing self goes wrongQ37995556
Antigen-specific tolerization approaches in multiple sclerosis.Q38154948
Recent progress concerning CpG DNA and its use as a vaccine adjuvantQ38168903
Established and novel disease-modifying treatments in multiple sclerosisQ38180157
Polymer multilayer tattooing for enhanced DNA vaccinationQ38499608
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target.Q38513283
Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunityQ38627493
Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunityQ39003459
Expanding antigen-specific regulatory networks to treat autoimmunityQ40787726
Rational design of small molecules as vaccine adjuvants.Q41655108
Nanoparticle hydrophobicity dictates immune responseQ42095803
Reversal of autoimmunity by boosting memory-like autoregulatory T cellsQ43104323
Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitisQ44264011
P4510describes a project that usesImageJQ1659584
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectimmunologyQ101929
polyelectrolytesQ901016
P304page(s)9334-9345
P577publication date2016-09-07
P1433published inACS NanoQ2819067
P1476titleDesign of Polyelectrolyte Multilayers to Promote Immunological Tolerance
P478volume10

Reverse relations

cites work (P2860)
Q39271088Biomaterial strategies for generating therapeutic immune responses
Q47846395Control of autoimmune inflammation using liposomes to deliver positive allosteric modulators of metabotropic glutamate receptors
Q53064170Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine.
Q93005872Engineering Cell Surfaces with Polyelectrolyte Materials for Translational Applications
Q52674872Engineering Immunological Tolerance Using Quantum Dots to Tune the Density of Self-Antigen Display.
Q39230209Engineering self-assembled materials to study and direct immune function
Q36225449Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters).
Q47676665Improving Vaccine and Immunotherapy Design Using Biomaterials
Q39245827In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.
Q48630939Modulating the immune system through nanotechnology.
Q64904747Multicomponent peptide assemblies.
Q48016268Polyplexes assembled from self-peptides and regulatory nucleic acids blunt toll-like receptor signaling to combat autoimmunity.
Q91789130Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastoma
Q98735466Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses
Q38695565Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling.
Q48504870Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity

Search more.